Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 9, 2026

EXL granted 10 new patents in the last year for AI solutions

View original at finance.yahoo.com
EXL granted 10 new patents in the last year for AI solutions EXL EXL’s patents for transforming data, enabling AI workflows and enhancing decision intelligence deliver measurable growth, savings, compliance and enhanced customer engagement NEW YORK, Feb…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • EXL Insurance LLM achieves 20-30% higher accuracy in claims and underwriting tasks than leading general-purpose models

    80% confidence
  • EXLdata.ai is a first-of-its-kind agentic AI-native suite of data solutions

    80% confidence
  • EXL is embedding decision intelligence directly into enterprise operations, enabling clients to operate faster, reduce costs, and improve customer outcomes with confidence

    80% confidence
  • These patents underscore EXL's commitment to innovation and to building differentiated data and AI capabilities that deliver measurable outcomes for clients

    80% confidence
  • EXL Insurance LLM is the first industry-specific large language model created to augment claim adjudication outcomes for bodily injury claims

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com